News
January 13, 2012 — Amorcyte Inc., a NeoStem Inc. company, announced the expansion of intellectual property protection around its lead product candidate, AMR-001, with the grant of U.S. patent number 8,088,370 by the United States Patent and Trademark Office. Amorcyte's first issued patent (7,794,705) entitled "Compositions and Methods of Vascular Injury Repair," protects a chemotactic stem cell product enriched for CD34+ cells that treats injury from acute myocardial infarction (AMI). The new patent covers the use of AMR-001 in the repair of any vascular injury caused by vascular insufficiency, and effectively expands the breadth of the patented claims beyond the current target indications for AMR-001.
January 13, 2012
News
January 13, 2012 – The U.S. Food and Drug Administration (FDA) is updating healthcare professionals and the public about preliminary findings from ongoing investigations following the voluntary recall of CardioGen-82 last July by the manufacturer, Bracco Diagnostics. CardioGen-82 consists of a generator that is used at clinical sites to produce rubidium (Rb)-82 chloride injection. A CardioGen-82 positron emission tomography (PET) scan is one of a variety of nuclear medicine scans that use radioactive drugs to evaluate myocardial perfusion.
January 13, 2012
Feature
January 12, 2011 – U.S. healthcare spending experienced historically low rates of growth in 2009 and 2010 according to the annual report of national health expenditures (NHE) published in the January issue of the journal Health Affairs.
January 12, 2012Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
January 12, 2012 – Geoffrey A. Rose, M.D., FASE, FACC, was recently appointed chairperson of the Intersocietal Accreditation Commission (IAC). Headquartered in Ellicott City, Md., the IAC is a national, nonprofit organization in operation to evaluate and accredit medical facilities.
January 12, 2012
News
January 12, 2012 – Stereotaxis Inc. (announced the completion of the first 50 clinical procedures using the company's new Niobe ES system to treat patients with a variety of complex cardiac arrhythmias. A majority of the first 50 cases were performed to treat atrial fibrillation (AF), the most common type of cardiac arrhythmia. Positive initial results with the Niobe ES system in Europe demonstrate that the average time for completion of mapping and ablation for the initial AF patients was 69 minutes. The data will be featured at the Boston Atrial Fibrillation Symposium 2012 to be held on January 12-14, 2012.
January 12, 2012
Feature
January 12, 2012 – Access to capital, a burdensome and uncertain regulatory environment, and lack of innovation and productivity in research and development are the biggest threats to the biomedical industry's growth over the next five years, according to biomedical company CEOs surveyed by CHI-California Healthcare Institute, BayBio and PwC US.
January 12, 2012Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Technology
January 12, 2012 – Masimo announced U.S. Food and Drug Administration (FDA) 510(k) clearance and full market commercial launch of the Masimo Pronto-7—a palm-sized handheld device designed for quick and easy noninvasive spot-checking of total hemoglobin (SpHb), SpO2, pulse rate, and perfusion index.
January 12, 2012
Technology
January 12, 2012 — Simbionix USA Corp. recently announced advanced virtual reality (VR) simulators that can communicate in Chinese, Japanese and Russian, in addition to English.
January 12, 2012News
January 12, 2012 — A project led by The American Society of Echocardiography (ASE) will utilize the latest technological innovations in the field to bring cardiovascular ultrasound to rural India.
January 12, 2012Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Feature
January 12, 2012 — An article in the January issue of the Journal of the American College of Radiology summarizes methods for radiation dose optimization in pediatric computed tomography (CT) scans.
January 12, 2012
News
January 11, 2012 — HeartWare International, Inc. and Dualis MedTech GmbH, a subsidiary of AVRA Surgical, Inc., announced an agreement to develop ventricular assist devices with wireless, transcutaneous energy transfer system (TETS) technology exclusively for HeartWare.
January 11, 2012
Technology
January 11, 2012 – Siemens Healthcare has announced that the version 2.0 of the Acuson SC2000 volume imaging ultrasound system has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
January 11, 2012Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News
January 9, 2012 – Janssen Research and Development, LLC (JRD) announced today that it has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the use of Xarelto (rivaroxaban), an oral anticoagulant, to reduce the risk of (thrombotic) cardiovascular events in patients with acute coronary syndrome (ACS).
January 09, 2012
News
January 9, 2012 - Uninsured patients, and those with Medicaid, receive far less imaging services than those with private insurance during emergency department (ED) visits, according to a study in the January issue of the Journal of the American College of Radiology.
January 09, 2012
Technology
January 9, 2012 - GE Healthcare announced the Brivo NM615 has received clearance from the U.S. Food and Drug Administration (FDA).
January 09, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now